The sign-off is said to be the first time a major vaccine has been approved in an African country ahead of rich nations – and it could end up saving countless lives.
Ghana has become the first country in the world to approve a new malaria vaccine developed by Oxford University.
R21/Matrix-M was shown to be up to 80% effective in a trial involving 400 children in Burkina Faso, published in September.
Malaria kills more than 600,000 people each year, most of them children in Africa, and the search for a vaccine has been going on for decades.
Image Credit: Tom Wilkinson, University of Oxford